Medication info
Pimaropine Tablet 30/2.5 mg

Pimaropine Tablet 30/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›33.005mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
White, rounded square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300084 · Approved 2023.01.06 · Insurance code 643105670

Summary

Main use
Treatment of essential hypertension not adequately controlled with fimasartan potassium monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is required for older adults aged 70 years or younger. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in children and adolescents aged 18 years or younger.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with fimasartan potassium monotherapy

  • Essential hypertension
View approved original text

This medication is used to lower blood pressure and help manage hypertension, particularly in cases where pimasartan monotherapy does not sufficiently control blood pressure necessitating additional treatment. Appropriate treatment methods are adjusted based on the patient's condition to effectively improve hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is required for older adults aged 70 years or younger. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in children and adolescents aged 18 years or younger.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, thus it must be discontinued immediately upon confirmation of pregnancy. It should not be administered to those with allergies to the active ingredients or related components, pregnant or breastfeeding individuals, patients undergoing renal dialysis, patients with moderate to severe liver impairment, patients with biliary obstruction, patients with specific kidney diseases and diabetes, individuals with lactose intolerance or certain genetic conditions, severe aortic stenosis patients, and patients in a shock state. Patients with low blood volume or sodium levels, individuals with impaired renal function, patients with renal vascular hypertension, patients with aortic and mitral valve stenosis, those with primary aldosteronism, patients with severe hypotension, elderly individuals, and those allergic to specific dyes included in this medication must take special care when using it. Various side effects such as dizziness, headaches, facial swelling, urinary disorders, insomnia, and flushing may occur, and if any unusual symptoms appear, the medical staff should be consulted. Blood pressure may drop too low during use, especially if blood volume or sodium is low, so symptoms of hypotension must be monitored, and appropriate measures should be taken if necessary. There is a risk of elevated potassium levels in blood during this medication use, so patients with heart failure or kidney diseases require regular blood tests. Drug interactions may occur if used with other antihypertensive drugs or specific medications, so if any other medications are being taken, it is crucial to inform the healthcare provider. This drug may have serious effects on the fetus during pregnancy, so it should not be used if planning a pregnancy or if pregnant, and it is not recommended during breastfeeding. For children under 18 years of age, the safety and efficacy of this medication have not been established, and it is advisable not to use it. For elderly individuals, no special dosage adjustment is necessary, but they should be cautious as they may respond more sensitively to the medication. It is safer not to administer this medication to patients with moderate to severe liver function impairment. Overdose may lead to serious symptoms such as hypotension, palpitations, and reflex tachycardia, requiring immediate medical attention.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urination disorder
  • insomnia
  • flushing
  • syncope
  • sedation
Show 130 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • epigastric pain
  • asthenia
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • pruritus
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal cancer
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • pulmonary disease
  • death
  • worsening of back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • asthenia
  • fatigue
  • pain
  • weight gain
  • weight loss
  • increased tension
  • sensory deficits
  • sensory abnormalities
  • peripheral neuropathy
  • taste disturbances
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gingival hyperplasia
  • pancreatitis
  • hyperglycemia
  • arthralgia
  • back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • dyspnea
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • urination disorder
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • rash
  • vascular edema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • diarrhea
  • loose stools
  • constipation
  • skin erythema
  • maculopapular rash
  • dizziness
  • heat sensation
  • impaired glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and must be stored in an opaque container. Also, it is safe to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White, rounded square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.